T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Intel
INTC
|
+$1.59B |
| 2 |
Dollar General
DG
|
+$1.53B |
| 3 |
Charles Schwab
SCHW
|
+$1.19B |
| 4 |
Uber
UBER
|
+$971M |
| 5 |
Nike
NKE
|
+$868M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$2.83B |
| 2 |
Amazon
AMZN
|
+$2.33B |
| 3 |
NVIDIA
NVDA
|
+$1.75B |
| 4 |
Humana
HUM
|
+$1.46B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$1.38B |
Sector Composition
| 1 | Technology | 31.18% |
| 2 | Healthcare | 15.82% |
| 3 | Financials | 11.11% |
| 4 | Consumer Discretionary | 10.8% |
| 5 | Communication Services | 8.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1026
Eastman Chemical
EMN
$7.8B
| $14.3M | ﹤0.01% |
158,724
-1
| -0% | -$90 |
|
1027
Universal Health Services
UHS
$12.1B
| $14.2M | ﹤0.01% |
93,449
+3,031
| +3% | +$462K |
|
1028
F5
FFIV
$19.2B
| $14.2M | ﹤0.01% |
79,481
+2,930
| +4% | +$524K |
|
1029
Permian Resources
PR
$9.8B
| $14.2M | ﹤0.01% |
1,042,273
+907,737
| +675% | +$12.3M |
|
1030
Bio-Rad Laboratories Class A
BIO
$7.74B
| $14.2M | ﹤0.01% |
43,834
-2,113
| -5% | -$682K |
|
1031
Autoliv
ALV
$9.8B
| $14.1M | ﹤0.01% |
127,497
+6,837
| +6% | +$753K |
|
1032
C.H. Robinson
CHRW
$15.5B
| $13.9M | ﹤0.01% |
161,203
+1,645
| +1% | +$142K |
|
1033
Robert Half
RHI
$3.7B
| $13.9M | ﹤0.01% |
158,010
+5,560
| +4% | +$489K |
|
1034
Boston Properties
BXP
$12.1B
| $13.7M | ﹤0.01% |
194,753
+2,703
| +1% | +$190K |
|
1035
Pacira BioSciences
PCRX
$1.21B
| $13.6M | ﹤0.01% |
403,753
-5,236
| -1% | -$177K |
|
1036
Etsy
ETSY
$5.91B
| $13.5M | ﹤0.01% |
166,368
-2,431,901
| -94% | -$197M |
|
1037
Carlisle Companies
CSL
$16.8B
| $13.4M | ﹤0.01% |
42,952
+1,006
| +2% | +$314K |
|
1038
AtriCure
ATRC
$1.87B
| $13.3M | ﹤0.01% |
373,761
-60,722
| -14% | -$2.17M |
|
1039
Ambev
ABEV
$35.7B
| $13.3M | ﹤0.01% |
4,763,220
-232,300
| -5% | -$650K |
|
1040
Amylyx Pharmaceuticals
AMLX
$1.06B
| $13.2M | ﹤0.01% |
894,780
+870,560
| +3,594% | +$12.8M |
|
1041
Petrobras
PBR
$81.6B
| $13.2M | ﹤0.01% |
824,377
| – | – |
|
|
JNPR
1042
DELISTED
Juniper Networks
JNPR
| $13.1M | ﹤0.01% |
444,857
-8
| -0% | -$236 |
|
1043
Supernus Pharmaceuticals
SUPN
$2.62B
| $12.9M | ﹤0.01% |
445,316
-32,064
| -7% | -$928K |
|
|
NVEE
1044
DELISTED
NV5 Global
NVEE
| $12.9M | ﹤0.01% |
463,792
-198,900
| -30% | -$5.53M |
|
1045
Lyell Immunopharma
LYEL
$256M
| $12.9M | ﹤0.01% |
331,944
-2,366
| -0.7% | -$91.8K |
|
1046
KBR
KBR
$6.38B
| $12.8M | ﹤0.01% |
230,297
+5,444
| +2% | +$302K |
|
1047
LCI Industries
LCII
$2.52B
| $12.7M | ﹤0.01% |
101,144
-7,738
| -7% | -$973K |
|
1048
Magnolia Oil & Gas
MGY
$4.47B
| $12.6M | ﹤0.01% |
592,549
-1,948,273
| -77% | -$41.5M |
|
1049
BorgWarner
BWA
$9.6B
| $12.5M | ﹤0.01% |
348,832
+5,615
| +2% | +$201K |
|
1050
Hormel Foods
HRL
$14B
| $12.4M | ﹤0.01% |
387,237
+1
| +0% | +$32 |
|